predicting new molecular targets known drugs 
although drugs intended selective least bind several physiological targets explaining side effects efficacy many drug-target combinations exist useful explore possible interactions computationally compared us food drug administration fda-approved investigational drugs hundreds targets defining target ligands chemical similarities drugs ligand sets predicted thousands unanticipated associations thirty tested experimentally including antagonism beta receptor transporter inhibitor prozac inhibition hydroxytryptamine -ht transporter ion channel drug vadilex antagonism histamine h receptor enzyme inhibitor rescriptor overall new drug-target associations confirmed five potent < nm physiological relevance one drug nn-dimethyltryptamine dmt serotonergic receptors confirmed knockout mouse chemical similarity approach systematic comprehensive may suggest side-effects new indications many drugs 
